Mr Paul Fields

Mr Paul Fields

BA (Hons), MA, PGCert, FHEA

Connect with Paul

Email: p.fields@soton.ac.uk

Publications

1 publication

Page 1 of 1

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)

Adam Gibb,

Sarah J Pirrie,

Kim Linton,

Victoria Warbey,

Kathryn Paterson,

Andrew J Davies,

Graham P Collins,

Tobias Menne,

Pamela McKay,

Paul A Fields,

Fiona M Miall,

Eszter Nagy,

Keith Wheatley,

Rachel Reed,

Ivona Baricevic-Jones,

Sally Barrington,

& John Radford

, 2020 , British Journal of Haematology

DOI: 10.1111/bjh.17073

Type: article

How to edit profile

Back to top